openPR Logo
Press release

Vaginal Mesh Lawsuits Have Senate Seeking Increased Safety Measures

12-21-2011 04:48 AM CET | Politics, Law & Society

Press release from: Nadrich & Cohen LLP

Los Angeles, CA, December 20, 2011 – Nadrich & Cohen LLP reports that the U.S. Senate has proposed a new piece of legislation aimed at reducing the number of consumers who suffer serious injuries caused by a defective medical device. The bill, which would require manufacturers to conduct ongoing safety studies of these devices after obtaining FDA approval, was drafted in part as a response to the growing number of lawsuits filed against the makers of problematic vaginal mesh implants.

Currently, the Food and Drug Administration allows certain medical devices to be approved under its 510(k) system. Based on these guidelines, manufacturers need only to demonstrate that their product is substantially similar to one already on the market. The Senate cites the 2010 recall of the DePuy ASR hip implant system, which was approved under the 510(k) rule, as evidence that the guidelines are ineffective in ensuring public safety.

In addition to drafting the legislation, senators have sent letters to several vaginal mesh manufacturers, including Bard and Johnson & Johnson, requesting additional information about how the devices are checked for safety and how a recall is handled if deemed necessary.

C.R. Bard is facing hundreds of lawsuits from women who claim that its Avaulta transvaginal mesh system caused scarring, pain, bleeding, blood vessel damage and other complications. Johnson & Johnson faces a similar number of suits from women who say they were injured by the company’s Ethicon Gynecare mesh system. The first bellweather trials in the Johnson & Johnson cases are scheduled to begin in a New Jersey federal court in November 2012.

Since 2008, the FDA has received thousands of complaints from women who allege serious side effects caused by mesh devices. In June 2011, an updated safety warning was issued, warning both physicians and consumers of the potential risk.

In November 2011, the American College of Obstetricians and Gynecologists (The College) and the American Urogynecologic Society (AUGS) issued a joint statement recommending the limited use of transvaginal mesh. The FDA is continuing its ongoing safety review of vaginal mesh implants but as of yet, there are no plans to issue a recall of these products.

Nadrich & Cohen LLP is actively investigating claims from women in all 50 states who say they were seriously injured by a vaginal mesh device. For more information about filing a defective medical device injury lawsuit, call 1-800-722-0765 or visit the firm’s online mesh resource center at www.VaginalMeshLegalClaims.com.

Nadrich & Cohen LLP is a California-based law firm which specializes in representing injured persons in complex individual and class action lawsuits nationwide. The firm is currently investigating claims from clients who have been harmed by dangerous prescription drugs, defective medical devices and faulty consumer products.

Jennifer Poole
National Client Intake Coordinator
Nadrich & Cohen LLP
12100 Wilshire Blvd., Suite 1250
Los Angeles, CA 90025
800-718-4658
www.personalinjurylawcal.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Vaginal Mesh Lawsuits Have Senate Seeking Increased Safety Measures here

News-ID: 204899 • Views:

More Releases from Nadrich & Cohen LLP

Yaz Lawsuit Settlements Reach $142 Million
Nadrich & Cohen, LLP reports that Bayer is continuing to offer settlements to plaintiffs involved in federal Yaz side effects litigation. Los Angeles, CA, April 27, 2012 – Nadrich & Cohen, LLP reports that German drug-maker Bayer AG has settled approximately 651 Yaz side effects lawsuits totaling $142 million. Earlier this month, it was reported that the drug-maker had reached settlements in approximately 500 cases filed by women who claimed
Yaz, Yasmin to Get New Labels as FDA Warns of Blood Clot Risk
Nadrich & Cohen, LLP reports that Yaz and similar birth control pills are to receive updated warning labels advising patients of the risk for developing serious blood clots. Los Angeles, CA, April 10, 2012 – National law firm Nadrich & Cohen, LLP has learned that the U.S. Food and Drug Administration has ordered Bayer to produce new warning labels for several of its oral contraceptives, including Yaz, Yasmin and Beyaz.
FDA Schedules Advisory Panel Meeting to Discuss Metal Hip Safety
Nadrich & Cohen, LLP reports that the FDA has scheduled an advisory panel to discuss the safety of metal hip implants. Los Angeles, CA, March 29, 2012 – National law firm Nadrich & Cohen, LLP has learned that the U.S. Food and Drug Administration has a scheduled an advisory panel meeting to discuss the safety of metal hip implants and all-metal hip resurfacing systems. The two-day panel, which is expected
Pradaxa Side Effects Lawsuits Filed in Federal Court
Nadrich & Cohen, LLP reports that three Pradaxa side effects lawsuits have been filed in federal courts across the country. Los Angeles, CA, March 7, 2012 – National law firm Nadrich & Cohen, LLP has learned that three Pradaxa side effects lawsuits have been filed against Boehringer Ingelheim, the drug’s manufacturer. The cases were filed in federal district courts located in Tennessee, Kentucky and Louisiana and it’s believed they are the

All 5 Releases


More Releases for Johnson

Urgent Care Apps Market 2019 Analysis by Johnson & Johnson (Johnson & Johnson He …
"the Global Urgent Care Apps market is accounted for $312.93 million in 2017 and is expected to reach $6,382.75 million by 2026 growing at a CAGR of 39.8%. Growing demand owing to growing focus on patient-centric healthcare delivery and increase in penetration of 3G and 4G networks are some key factors influencing the market growth. However, poor internet connectivity in developing countries is restricting the growth of the market. In
Global Erythropoietin Market 2019 - Amgen, Johnson & Johnson, Roche
This new report by Eon Market Research, titled “Global Erythropoietin Market 2019 Research Report, 2015 – 2025” offers a comprehensive analysis of Erythropoietin industry at a global as well as regional and country level. Key facts analyzed in this report include the Erythropoietin market size by players, regions, product types and end industries, history data 2014-2018 and forecast data 2019-2025. This report primarily focuses on the study of the competitive
Biotechnology Market - Development Outlook 2025 | Pfizer, Johnson & Johnson
Global Biotechnology Market: Overview The global biotechnology market is mainly driven by the surge in the demand for food, depleting natural resources, government regulatory support, and technological advancements of various solutions to counter fatal diseases. The advent of stem cell technology, nanotechnology, and cloning has also propelled this market substantially and is expected to continue aiding to this market in the years to come. However, the dearth of awareness among consumers
Wet Tissues Market 2017- Johnson & Johnson, SC Johnson, Clorox, Beiersdorf, 3M
Apex Research, recently published a detailed market research study focused on the "Wet Tissues Market" across the global, regional and country level. The report provides 360° analysis of "Wet Tissues Market" from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global Wet Tissues industry, and estimates the future trend of Wet Tissues market on
Cytokines Market 2017 - AbbVie, Johnson & Johnson, GlaxoSmithKline, Sanofi
Apex Research, recently published a detailed market research study focused on the "Cytokines Market" across the global, regional and country level. The report provides 360° analysis of "Cytokines Market" from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global Cytokines industry, and estimates the future trend of Cytokines market on the basis of this
Global Facial Wipes Sales Market 2017 - Beiersdorf, Johnson & Johnson, SC Johnso …
The Global Facial Wipes Sales Industry report gives a comprehensive account of the Global Facial Wipes Sales market. Details such as the size, key players, segmentation, SWOT analysis, most influential trends, and business environment of the market are mentioned in this report. The report features an up-to-date data on key companies product details, revenue figures, and sales. The business model strategies of the key firms in the Facial Wipes Sales